Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis

Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) currently lacks a robust and well-defined biomarker that can 1) assess the progression of the disease, 2) predict and/or delineate the various clinical subtypes, and 3) evaluate or predict a patient’s response to treatments. The kynurenine Pathway (KP) of tryptoph...

Full description

Bibliographic Details
Main Authors: Vanessa X. Tan, Gilles J. Guillemin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-09-01
Series:Frontiers in Neuroscience
Subjects:
kynurenine pathway
amyotrophic lateral sclerosis
biomarker development
neurodegeneration
motor neuron disease
neuroinflammation and neurodegeneration
Online Access:https://www.frontiersin.org/article/10.3389/fnins.2019.01013/full

Similar Items

Similar Items